Multifaced Impact of Current Medical Treatments to The Outcomes of Immunotherapy of Liver Cancer

3,472
Total downloads
21k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 18 Aug 2026

The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study

Xinge Li
Yunlong Dong
Wen Chen
Yan Wang
Pengfei Sun
Xu Chang
Chunxue Wu
Dianzhe Wang

doi 10.3389/fimmu.2026.1782185

316 views

REVIEW

Published on 22 Jul 2026

From anatomical to biological resectability: navigating adaptive resistance in hepatocellular carcinoma conversion

Shitao Lei
Yun Cong
Yuhang Yang
Yaoqiang Bao
Wei Huang
Yingmei Shao

doi 10.3389/fonc.2026.1849485

582 views

ORIGINAL RESEARCH

Published on 17 Jul 2026

Efficacy and safety of CalliSpheres drug-eluting bead transarterial chemoembolization for unresectable gastrointestinal stromal tumor liver metastases after failure of targeted therapy: a multicenter retrospective study

Song Liu
Ting Chen
Shunhang Yin
Guangji Yu
Qingdong Wang
Long Li
Guangsheng Zhao
Lei Zhang
Buqiang Zhuang

doi 10.3389/fonc.2026.1784905

487 views

ORIGINAL RESEARCH

Published on 29 Jun 2026

Efficacy and safety of combining TACE with atezolizumab/bevacizumab versus TACE alone: a retrospective propensity score-matched cohort study in HBV-related hepatocellular carcinoma

Jie Feng
Guocheng Lin
Yeyan Wang

doi 10.3389/fonc.2026.1840779

790 views

ORIGINAL RESEARCH

Published on 01 Jun 2026

Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy

Chao Chen
Yang Wang
Yan Zhao
Wenyan Cao
Ao Chen
Xiufeng Liu
Zhan Shi
Jie Shen

doi 10.3389/fonc.2026.1756928

911 views

ORIGINAL RESEARCH

Published on 20 May 2026

Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal vein tumor thrombosis: a retrospective cohort study

Weifu Liu
Kongzhi Zhang
Shiguang Chen
Xiaolong Wang
Wenchang Yu

doi 10.3389/fimmu.2026.1832313

1,537 views
1 citation

ORIGINAL RESEARCH

Published on 22 Apr 2026

Establishment and validation of a CT-based clinical deep learning radiomics nomogram for predicting the response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Genxiang Chen
Bo Li
Aijun Liu
Bin Li
Yong Mei
Li Tan
Jing Chen
Zhiyuan Hao

doi 10.3389/fonc.2026.1773400

1,156 views

REVIEW

Published on 15 Apr 2026

Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside

Chenfang Zhang
Dan Zhang
Xin Wen
Shui Liu

doi 10.3389/fimmu.2026.1808109

2,709 views
2 citations

REVIEW

Published on 10 Apr 2026

Perioperative immunotherapy for hepatocellular carcinoma: adjuvant, neoadjuvant, and biomarker-guided strategies

Kangrui Li

doi 10.3389/fmed.2026.1811918

2,383 views
1 citation

CASE REPORT

Published on 04 Mar 2026

Marked effect of topical application of Chinese medicine combined with moxibustion in a case of refractory malignant ascites in diffuse liver cancer

Dou-dou Feng
Xing-ping Zhang
Lei Guo
Chuan He

doi 10.3389/fmed.2026.1751741

2,145 views
1 citation

ORIGINAL RESEARCH

Published on 20 Feb 2026

Dynamics of peripheral immune signature identified by multi-omics and its impact on recurrence after radiofrequency ablation of hepatocellular carcinoma

Kang Li
Wanting Shi
Yongjun Li
Yi Song
Baochen Du
Jinxia Guan
Jianjun Li
Dandan Guo
Tingting Mei
1 more
Yonghong Zhang

doi 10.3389/fimmu.2026.1760329

913 views

REVIEW

Published on 10 Feb 2026

HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management

Yurou Jin
Chao Jin
Ronghui Xie
Jingming Zhang
Guangmin Wei
Ling Zheng

doi 10.3389/fimmu.2026.1765054

2,718 views
2 citations

Share on

Frontiers in Medicine

Hepatobiliary Diseases

Other participating journals

Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- 7.0 impact factor
- 11.3 citescore
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.4 impact factor
- 6.6 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

21kTopic views
16kArticle views
3,472Article downloads

View impact

Articles

The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study

From anatomical to biological resectability: navigating adaptive resistance in hepatocellular carcinoma conversion

Efficacy and safety of CalliSpheres drug-eluting bead transarterial chemoembolization for unresectable gastrointestinal stromal tumor liver metastases after failure of targeted therapy: a multicenter retrospective study

Efficacy and safety of combining TACE with atezolizumab/bevacizumab versus TACE alone: a retrospective propensity score-matched cohort study in HBV-related hepatocellular carcinoma

Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy

Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal vein tumor thrombosis: a retrospective cohort study

Establishment and validation of a CT-based clinical deep learning radiomics nomogram for predicting the response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside

Perioperative immunotherapy for hepatocellular carcinoma: adjuvant, neoadjuvant, and biomarker-guided strategies

Marked effect of topical application of Chinese medicine combined with moxibustion in a case of refractory malignant ascites in diffuse liver cancer

Dynamics of peripheral immune signature identified by multi-omics and its impact on recurrence after radiofrequency ablation of hepatocellular carcinoma

HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management

Frontiers in Medicine

Hepatobiliary Diseases

Other participating journals

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Frontiers in Oncology

Cancer Immunity and Immunotherapy